Bioatla share price today

(BCAB)

Bioatla share price is $1.45 & ₹122.90 as on 14 Dec 2024, 2.30 'hrs' IST

$1.45

▲

0.02

(1.4%)

Market is closed - opens 8 PM, 16 Dec 2024

View live Bioatla share price in Dollar and Rupees. Guide to invest in Bioatla from India. Also see the sentimental analysis on Indian investors investing in Bioatla. Get details on the Indian mutual funds that are investing in Bioatla. Get Analyst recommendations and forecasts along with all the Bioatla's financials.

Bioatla share price movements

$1.43
$1.49
$1.45
1.38%
Downside
Day's Volatility :4.03%
Upside
2.68%
$1.14
$4.02
$1.45
21.38%
Downside
52 Weeks Volatility :71.64%
Upside
63.93%

Bioatla Returns

Period	Bioatla Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-14.88%	-9.7%	0.0%
6 Months	-8.33%	-3.4%	0.0%
1 Year	-32.23%	3.7%	0.0%
3 Years	-93.21%	3.8%	-18.9%

Bioatla Key Statistics

in dollars & INR

Previous Close	$1.43
Open	$1.46
Today's High	$1.49
Today's Low	$1.43
Market Capitalization	$74.0M
Today's Volume	$804.2K
52 Week High	$4.02
52 Week Low	$1.14
Revenue TTM	$11.0M
EBITDA	$-85.2M
Earnings Per Share (EPS)	$-1.7
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-139.06%

How to invest in Bioatla from India?

It is very easy for Indian residents to invest directly in Bioatla from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioatla stock in both rupees (INR) and dollars (USD). Search for Bioatla or BCAB on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioatla or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioatla shares which would translate to 0.585 fractional shares of Bioatla as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Bioatla

30%

Period: Sep 14, 2024 to Dec 13, 2024. Change in 30 Days versus previous period

Search volume for Bioatla on INDmoney from India has grown in the last 30 days as on Dec 14, 2024. 30% more investors are searching Bioatla in the last 30 days versus the previous period.

Global Institutional Holdings in Bioatla

Millennium Management LLC
5.50%
Soleus Capital Management, L.P.
5.21%
Vanguard Group Inc
3.90%
Morgan Stanley - Brokerage Accounts
3.84%
TANG CAPITAL MANAGEMENT LLC
1.81%
BlackRock Inc
1.64%

Analyst Recommendation on Bioatla

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Bioatla(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bioatla

What analysts predicted

Upside of 520.69%

Current:

$1.45

Target:

$9.00

Insights on Bioatla

Price Movement
In the last 7 days, BCAB stock has moved down by -12.8%
BCAB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.9% return, outperforming this stock by 68.4%
BCAB vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 31.6% return, outperforming this stock by 125.0%
Price to Sales
ForBCAB every $1 of sales, investors are willing to pay $6.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.8 for every $1 of sales.

Bioatla Technicals Summary

Sell

Neutral

Buy

Bioatla is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bioatla Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bioatla Inc	-28.14%	-8.33%	-32.23%	-93.21%	-95.39%
Regeneron Pharmaceuticals, Inc.	-7.88%	-29.12%	-13.75%	12.62%	97.06%
Biontech Se	8.26%	36.47%	18.09%	-57.96%	244.83%
Alnylam Pharmaceuticals, Inc.	-7.31%	55.92%	32.4%	28.37%	104.18%
Vertex Pharmaceuticals Incorporated	-6.16%	-2.02%	13.01%	119.83%	111.44%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bioatla Inc	NA	NA	NA	-1.52	-1.39	-0.5	NA	0.48
Regeneron Pharmaceuticals, Inc.	19.12	19.12	1.15	45.03	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.12	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bioatla Inc	Buy	$74.0M	-95.39%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$84.9B	97.06%	19.12	33.61%
Biontech Se	Buy	$28.6B	244.83%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.8B	104.18%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	111.44%	32.84	-4.51%

About Bioatla

bioatla is a protein therapeutic company that uses discovery and evolution to develop safer and more potent drugs for the treatment of cancer. the culmination of our discovery and evolution expertise and more than 150 issued patents and patent applications is our conditionally active biologics (cab) platform, whereby monoclonal antibodies or other biologics can be engineered for selective conditional activation, for example preferential binding under the unique conditions of the tumor microenvironment. this improvement in tumor selectivity helps address the issue of on-target toxicity and improve therapeutic index. bioatla is applying these technologies in our own pipeline and in partnerships to ultimately deliver better immunotherapies for cancer.

Organization	Bioatla
Employees	65
CEO	Dr. Jay M. Short Ph.D.
Industry	Healthcare

Management People of Bioatla

Name	Title
Dr. Jay M. Short Ph.D.	Co-Founder, CEO & Chairman
Mr. Richard A. Waldron	Senior VP & CFO
Dr. Eric L. Sievers M.D.	Chief Medical Officer
Mr. Christian J. Vasquez CPA	Chief Accounting Officer, Controller and Corporate Secretary
Ms. Susie Melody	Senior Vice President of Human Resources
Dr. Cathy Chang Ph.D.	Senior Vice President of Research & Development
Dr. Gerhard Frey Ph.D.	Senior Vice President of Technology Development
Ms. Monica Sullivan	Senior Vice President of Intellectual Property & Contracts
Ms. Sheri Lydick	Chief Commercial Officer
Lisa M. Pelton	Accounting Manager

Important FAQs about investing in Bioatla from India :

What is Bioatla share price today?

Bioatla share price today stands at $1.45, Open: $1.46 ; Previous Close: $1.43 ; High: $1.49 ; Low: $1.43 ; 52 Week High: $4.02 ; 52 Week Low: $1.14. The stock opens at $1.46, after a previous close of $1.43. The stock reached a daily high of $1.49 and a low of $1.43, with a 52-week high of $4.02 and a 52-week low of $1.14.

Can Indians buy Bioatla shares?

Yes, Indians can invest in the Bioatla (BCAB) from India.

With INDmoney, you can buy Bioatla at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bioatla at zero transaction cost.

How can I buy Bioatla shares from India?

It is very easy to buy Bioatla from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioatla be purchased?

Yes, you can buy fractional shares of Bioatla with INDmoney app.

What are the documents required to start investing in Bioatla stocks?

To start investing in Bioatla, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.